Laser brain cancer
treatment may bring extra advantage
Send a link to a friend
[May 05, 2016]
By Ben Gruber
ST. LOUIS (Reuters) - Neurosurgeons using
lasers to treat brain cancer have discovered that the technique breaks
down the blood-brain barrier, a finding that could lead to new treatment
options for patients with the deadly disease.
|
The blood-brain barrier is sort of a natural "security system" that
shields the brain from toxins in the blood but also blocks
potentially helpful drugs such as chemotherapy.
"We were able to show that this blood-brain barrier is broken down
for about four weeks after you do this laser therapy," said Dr. Eric
Leuthardt, a professor of neurosurgery at Washington University in
St. Louis.
"So not only are you killing the tumor, you are actually opening up
a window of opportunity to deliver various drugs and chemicals and
therapies that could otherwise not get there," Leuthardt added.
The study using lasers to treat people with brain cancer is now in a
so-called Phase II clinical trial in which a treatment is given to a
larger group of people than the initial phase to see if it is
effective and to further evaluate its safety.
The laser technology, approved by the U.S. Food and Drug
Administration in 2009 as a surgical tool to treat brain tumors,
involves a small laser-tipped probe that heats up and kills tumors
from the inside out.
As part of the trial, patients after the laser therapy are given the
powerful chemotherapy drug doxorubicin, known as one of the least
likely to penetrate the blood-brain barrier.
"Kind of makes you smile when they say you are a good candidate for
something new," said Kathy Smith, a participant in the clinical
trial who has been battling cancer since 2009.
Initially diagnosed with ovarian cancer, Smith is now being treated
for recurrent glioblastoma, one of the most difficult forms of brain
cancer to treat. Most patients diagnosed with these types of brain
tumors survive just 15 months, according to the American Cancer
Society.
[to top of second column] |
The trial is still ongoing but Leuthardt called the initial results
promising.
"What's interesting is that the blood-brain barrier is a two-way
street," Leuthardt said. "By breaking it down, you can get things
into the brain, but also by breaking it down now things can go from
your brain out into your circulation, to your peripheral system,
which includes your immune system."
Leuthardt said he is using drugs to "amplify the immune system to
fight the cancer" in combination with laser therapy.
The researchers hope to publish their findings later this year.
(Reporting by Ben Gruber; Editing by Will Dunham)
[© 2016 Thomson Reuters. All rights
reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|